New Brunswick, NJNCT06473779Now EnrollingIRB Ready

Severe Asthma Clinical Trial in New Brunswick, NJ

Access cutting-edge severe asthma treatment through this clinical trial at a research site in New Brunswick. Study-provided care at no cost to qualified participants.

Sponsored by AstraZeneca

Quick Self-Assessment

See if you qualify for this New Brunswick location

Preparing your pre-screening questions...

Expert Care in New Brunswick

Access severe asthma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related severe asthma treatment provided free

Apply for This New Brunswick Location

Check if you qualify for this severe asthma clinical trial in New Brunswick, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New Brunswick

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New Brunswick site if eligible
  4. 4Begin participation

About This Severe Asthma Study in New Brunswick

The objective of this study is to assess the potential for tezepelumab-treated patients (subcutaneous administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma.. Study details include: 1. The study duration will be up to 72 weeks. 2. The treatment duration will be up to 68 weeks. 3. The visit frequency will be once every 4 weeks (Q4W).

Sponsor: AstraZeneca

Who Can Participate

Inclusion Criteria

at Visit 1 (Screening): Informed Consent 1. Provision of signed and dated written ICF prior to any mandatory study-specific procedures, sampling, and analyses for patients who are at or over the age of majority (as per local law). For patients who are less than the age of majority, in addition to providing their informed consent, the patients' legally authorised representative must also provide their informed assent (Appendix A 3). Age 2. Patients must be 12 to 80 years of age inclusive, at the time of signing the ICF. Type of Patient and Disease Characteristics 3. Documented medical record history for at least 12 months prior to Visit 1. 4. Documented physician-diagnosed severe asthma within 10 years prior to Visit 1 (ie, severe asthma was not diagnosed more than 10 years prior) consisting of any of the following: 1. FEV1 \> 12% reversibility, OR 2. Evidence of airflow variability (to show that lung function is altered over time): FEV1 ≥ 400 mL vari

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New Brunswick?

Yes, this clinical trial (NCT06473779) has an active research site in New Brunswick, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Severe Asthma Treatment Options in New Brunswick, NJ

If you're searching for severe asthma treatment options in New Brunswick, NJ, this clinical trial (NCT06473779) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New Brunswick research site is actively enrolling participants for this clinical trial. You'll receive care from experienced severe asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all severe asthma clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in New Brunswick, NJ

See all ankylosing spondylitis clinical trials recruiting in New Brunswick — not just this study.

Browse Ankylosing Spondylitis Trials in New Brunswick →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsAsthma TrialsModerate-to-Severe Asthma TrialsAll Conditions →

Ready to Join in New Brunswick?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New Brunswick, NJ